About
Ekso Bionics designs and manufactures advanced exoskeleton systems that restore mobility to individuals with lower limb impairments caused by neurological conditions. Their flagship clinical product, EksoNR, is the only FDA-cleared exoskeleton approved for use in stroke, spinal cord injury, acquired brain injury, and multiple sclerosis rehabilitation — enabling physical therapists to mobilize patients early in their recovery journey across inpatient settings. Ekso Indego Therapy supports outpatient rehabilitation, helping patients with lower extremity weakness improve strength and walking ability. For home and community use, the Ekso Indego Personal is the lightest available personal exoskeleton, empowering individuals paralyzed from spinal cord injury (levels T3–L5) to stand, walk, and engage in daily life outside of clinical settings. Medicare coverage is available for eligible beneficiaries. With a global network of 500+ rehabilitation centers and an intuitive modular design, Ekso Bionics bridges the gap from hospital to home. The company also offers industrial exoskeleton solutions through EksoWorks, supporting worker ergonomics and injury prevention. Ekso Bionics serves physical therapists, rehabilitation hospitals, neurologists, and individuals living with mobility impairments worldwide.
Key Features
- FDA-Cleared Clinical Exoskeleton (EksoNR): The only FDA-cleared exoskeleton approved for stroke, spinal cord injury, acquired brain injury, and MS rehabilitation, enabling early patient mobilization in inpatient settings.
- Personal Home & Community Use (Ekso Indego Personal): The lightest available personal exoskeleton lets individuals with SCI (T3–L5) stand and walk at home and in their community, with possible Medicare coverage.
- Outpatient Therapy Support (Ekso Indego Therapy): Supports outpatient rehabilitation for patients with lower extremity weakness or paralysis from SCI or stroke, improving strength and walking ability.
- Global Network of Rehabilitation Centers: Over 500 rehabilitation centers worldwide are equipped with Ekso Bionics technology, making access to exoskeleton-assisted therapy broadly available.
- Modular & Adjustable Design: Ekso exoskeletons feature a modular, customizable design to accommodate diverse patient profiles and therapeutic goals across clinical and personal settings.
Use Cases
- Inpatient rehabilitation for stroke patients to begin gait training early in their recovery using EksoNR under physical therapist supervision.
- Outpatient therapy for individuals with spinal cord injury or stroke to progressively improve lower limb strength and walking endurance.
- Home and community mobility for individuals paralyzed by spinal cord injury (T3–L5) seeking independence beyond a wheelchair using Ekso Indego Personal.
- Neurological rehabilitation programs at hospitals and clinics treating patients with acquired brain injury or multiple sclerosis.
- Insurance-supported personal exoskeleton adoption for Medicare-eligible beneficiaries with qualifying spinal cord injuries.
Pros
- FDA-Cleared for Multiple Conditions: EksoNR holds FDA clearance for four neurological indications, giving clinicians and patients confidence in its safety and efficacy.
- Medicare Coverage Available: Eligible patients can access Ekso Indego Personal through Medicare, significantly reducing the financial barrier to personal exoskeleton ownership.
- Broad Clinical Adoption: With 500+ centers worldwide, Ekso Bionics has one of the largest rehabilitation network footprints in the exoskeleton industry.
- Full Continuum of Care: Products span inpatient, outpatient, and home/community use, allowing patients to use exoskeleton-assisted therapy throughout their entire recovery journey.
Cons
- High Cost: Exoskeleton devices represent a significant financial investment, and insurance coverage — while growing — is not universally available for all products and patients.
- Requires Professional Assessment: Patients must undergo clinical evaluation and work with trained physical therapists to qualify for and safely use the devices, limiting self-directed access.
- Limited Indication Range for Personal Use: Ekso Indego Personal is currently indicated only for SCI levels T3–L5, excluding individuals with higher-level or other types of injuries.
Frequently Asked Questions
What conditions can Ekso Bionics exoskeletons help with?
Ekso Bionics exoskeletons are designed for individuals with spinal cord injury (SCI), stroke, acquired brain injury (ABI), and multiple sclerosis (MS). Clinical products like EksoNR are FDA-cleared for all four of these indications.
Does Medicare cover Ekso Indego Personal?
Yes, Medicare may cover the Ekso Indego Personal when it is deemed reasonable and necessary based on a patient's medical condition and clinical documentation. Ekso Bionics offers a free consultation to help determine eligibility.
Can I use an Ekso exoskeleton at home?
Yes. Ekso Indego Personal is specifically designed for home and community use, allowing individuals with SCI at levels T3–L5 to stand and walk outside of a clinical environment.
How do I find a rehabilitation center that uses Ekso Bionics technology?
Ekso Bionics maintains a global network of 500+ rehabilitation centers. You can use their online 'Find a Center' tool on the website to locate the nearest facility offering Ekso technology.
What is the difference between EksoNR and Ekso Indego Therapy?
EksoNR is designed for inpatient rehabilitation and is FDA-cleared for stroke, SCI, ABI, and MS, allowing mobilization even before patients can stand independently. Ekso Indego Therapy is designed for outpatient rehab, focusing on improving strength and walking ability for patients with lower extremity weakness.
